Camber Specialty Capabilities
In 2022, Hetero and Camber Pharmaceuticals established Camber Specialty in response to the growing demand for high-quality, low-cost specialty medications supporting hospitals, clinics, oncology treatment centers, government, and other institutional customers.
Learn more about Camber Specialty in this short video.
Recent articles
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year
- Camber Launches Mycophenolate Mofetil Capsules
- Camber Launches Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution
- Camber’s Triple Play – Featured Generics
- Big Game Commercial
- Charting a Bold Path for 2025